Kenneth M. Zangwill - Concepedia

Author

Kenneth M. Zangwill

Also Known As

Anh Duong, K M Zangwill, K ZANGWILL, K Zangwill, K. M. Zangwill, K. Zangwill, K.M. Zangwill, KENNETH M. ZANGWILL, KENNETH ZANGWILL, Kenneth M Zangwill

Publications

4.1K

Citations

H-Index

Concepts

All Affiliations

Harbor–UCLA Medical Center UCLA Medical Center The Lundquist Institute Kaiser Permanente Centers for Disease Control and Prevention

About

Kenneth M. Zangwill is an author at Harbor–UCLA Medical Center specializing in medicine, pediatrics, and infection control.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	21	1.1K
2	Public Health	10	10	816
3	Epidemiology	7	7	729
4	Environmental Engineering	1	1	19
5	Health Law	1	1	40

Kenneth M. Zangwill

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine John J. Treanor, James D. Campbell, Kenneth M. Zangwill, New England Journal of Medicine	2006	696
Cat Scratch Disease in Connecticut -- Epidemiology, Risk Factors, and Evaluation of a New Diagnostic Test Kenneth M. Zangwill, Douglas H. Hamilton, Bradley A. Perkins, New England Journal of Medicine	1993	527
Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. Kenneth M. Zangwill, Anne Schuchat, Jay D. Wenger PubMed Invasive Gbs DiseaseUnited StatesReproductive EpidemiologyHealthcare-associated InfectionClinical Epidemiology	1992	280
Epidemiology of Invasive Pneumococcal Disease in Southern California: Implications for the Design and Conduct of a Pneumococcal Conjugate Vaccine Efficacy Trial Kenneth M. Zangwill, Constance M. Vadheim, Ann M. Vannier, The Journal of Infectious Diseases Vaccine HesitancyBacterial PathogensInvasive Pneumococcal DiseasePreventive MedicineAntimicrobial Stewardship	1996	198
Multistate case-control study of maternal risk factors for neonatal Group B streptococcal disease Anne Schuchat, KATHERINE DEAVER-ROBINSON, Brian D. Plikaytis, The Pediatric Infectious Disease Journal	1994	184
Safety of Trivalent Inactivated Influenza Vaccine in Children 6 to 23 Months Old Simon J. Hambidge, Jason M. Glanz, Eric K. France, JAMA	2006	138
Safety of the Trivalent Inactivated Influenza Vaccine Among Children Eric K. France, Jason M. Glanz, Stanley Xu, Archives of Pediatrics and Adolescent Medicine	2004	124
Cost-Effectiveness Analysis of an Intranasal Influenza Vaccine for the Prevention of Influenza in Healthy Children Bryan R. Luce, Kenneth M. Zangwill, Cynthia S. Palmer, PEDIATRICS	2001	115
Compliance With Multiple-Dose Vaccine Schedules Among Older Children, Adolescents, and Adults: Results From a Vaccine Safety Datalink Study Jennifer C. Nelson, Rachel Bittner, Lora Bounds, American Journal of Public Health	2009	108
Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children James C. King, Patricia Fast, Kenneth M. Zangwill, The Pediatric Infectious Disease Journal	2001	96

Page 1